08.26.2019
Improve Outcomes
$759,064.00
61 months
Skin Pathology in people with T1D: Impact of Insulin Infusion via Pump
Funding to investigate the tissue response to continuous subcutaneous insulin infusion (CSII) via pump in people with type 1 diabetes (T1D) and to develop a preliminary dataset describing skin pathology and metabolic changes at the CSII sites with varied insulins, duration of T1D, and length of pump use.